NCT03147976View on ClinicalTrials.gov

QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

May 2, 2018

Primary Completion Date

August 23, 2019

Study Completion Date

August 23, 2019

Conditions

Solid Tumor

Interventions

DRUG

AMG 337

6-{(1R)-1-\[8-fluoro-6-(1-methyl-1H-pyrazol-4- yl)\[1,2,4\]triazolo\[4,3-a\]pyridin-3-yl\]ethyl}-3-(2- methoxyethoxy)-1,6-naphthyridin-5(6H)-one•hydrate (1:1)

Trial Locations (1)

90245

Chan Soon-Shiong Institute for Medicine, El Segundo